Active, not recruitingEarly Phase 1NCT07519005
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
Studying Pulmonary interstitial glycogenosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xijing Hospital
- Principal Investigator
- Kefeng Dou, ProfessorDepartment of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University
- Intervention
- Ex vivo perfusion of six-gene-edited porcine liver(biological)
- Enrollment
- 1 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07519005 on ClinicalTrials.gov